Roche has received CE mark approval of its Elecsys neurofilament light chain (NfL) test, which is designed to detect neuroinflammation in patients with relapsing remitting multiple sclerosis (RRMS).

(RTTNews) - Swiss drug major Roche Holding AG (RHHBY) announced Monday the launch of the Elecsys IGRA SARS-CoV-2 test in countries that accept the CE Mark. The Elecsys IGRA SARS-CoV-2 test is intended ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The U.S. Food and Drug Administration (FDA) has cleared another blood test that could help doctors identify whether a patient's memory problems are likely caused by Alzheimer's disease. The new test, ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether a patient's memory problems are likely caused by Alzheimer's disease. The new test, called ...

The Elecsys IGRA TB test runs on Roche’s cobas immunoassay systems.

(RTTNews) - Roche (RHHBY) announced the launch of the Elecsys Anti-p53 immunoassay for the in vitro quantitative determination of anti-p53 antibodies. The test is used to aid physicians to diagnose ...

A new study published in the New England Journal of Medicine today shows that Roche’s Pre-eclampsia Elecsys ® blood test can predict which pregnant women will, and will not, develop pre-eclampsia, one ...

The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in adults diagnosed with relapsing remitting multiple sclerosis.1 This minimally invasive blood test enables ...